• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童期镰状细胞贫血患者的发育功能。

Developmental function in toddlers with sickle cell anemia.

机构信息

Department of Pediatrics (D-820), PO Box 016820, Miami, FL 33101, USA.

出版信息

Pediatrics. 2013 Feb;131(2):e406-14. doi: 10.1542/peds.2012-0283. Epub 2013 Jan 6.

DOI:10.1542/peds.2012-0283
PMID:23296434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3557401/
Abstract

BACKGROUND

Neurocognitive impairment occurs in children and adults with sickle cell anemia, but little is known about neurodevelopment in very young children. We examined the neurodevelopmental status of infants participating in the Pediatric Hydroxyurea Phase III Clinical Trial (Baby Hug) to determine relationships with age, cerebral blood flow velocity, and hemoglobin concentration.

METHODS

Standardized measures of infant neurodevelopment were administered to 193 infants with hemoglobin SS or hemoglobin S-β(0) thalassemia between 7 and 18 months of age at the time of their baseline evaluation. Associations between neurodevelopmental scores and age, family income, parent education, hemoglobin concentration, and transcranial Doppler velocity were examined.

RESULTS

Mean functioning on the baseline neurodevelopment scales was in the average range. There were no mental development scores <70 (impaired); 22 children had scores in the clinically significant range, 11 with impaired psychomotor scores and 11 with problematic behavior rating scores. Significantly poorer performance was observed with older age at baseline. Behavior rating scores were an average of 2.82 percentile points lower per month of age, with similar patterns observed with parent report using adaptive behavior scales. Parent-reported functional abilities and hemoglobin were negatively associated with higher transcranial Doppler velocities.

CONCLUSIONS

Whereas overall functioning was in the normal range, behavioral and adaptive function was poorer with older age, even in this very young group of children. Explanatory mechanisms for this association between poorer developmental function and older age need to be identified.

摘要

背景

镰状细胞贫血患儿和成人会出现神经认知障碍,但对非常年幼的儿童的神经发育知之甚少。我们检查了参与小儿羟基脲 III 期临床试验(Baby Hug)的婴儿的神经发育状况,以确定其与年龄、脑血流速度和血红蛋白浓度的关系。

方法

在基线评估时,193 名血红蛋白 SS 或血红蛋白 S-β(0)地中海贫血的婴儿年龄在 7 至 18 个月之间,对其进行了标准化的婴儿神经发育评估。检查了神经发育评分与年龄、家庭收入、父母教育程度、血红蛋白浓度和经颅多普勒速度之间的关系。

结果

基线神经发育量表的平均功能处于平均范围。没有智力发育评分<70(受损);22 名儿童的评分处于临床显著范围,11 名有受损的精神运动评分,11 名有问题的行为评分。基线时年龄较大的儿童观察到的表现明显较差。行为评分平均每月降低 2.82 个百分点,使用适应行为量表进行父母报告时也观察到类似的模式。父母报告的功能能力和血红蛋白与更高的经颅多普勒速度呈负相关。

结论

尽管整体功能处于正常范围,但行为和适应功能随着年龄的增长而变差,即使在这个非常年幼的儿童群体中也是如此。需要确定这种较差的发育功能与年龄较大之间的关联的解释机制。

相似文献

1
Developmental function in toddlers with sickle cell anemia.儿童期镰状细胞贫血患者的发育功能。
Pediatrics. 2013 Feb;131(2):e406-14. doi: 10.1542/peds.2012-0283. Epub 2013 Jan 6.
2
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.羟基脲与慢性输血用于维持镰状细胞贫血患儿经颅多普勒血流速度的比较——输血转换为羟基脲的经颅多普勒研究(TWiTCH):一项多中心、开放标签、3期、非劣效性试验。
Lancet. 2016 Feb 13;387(10019):661-670. doi: 10.1016/S0140-6736(15)01041-7. Epub 2015 Dec 6.
3
Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial.羟基脲治疗可降低镰状细胞贫血伴高颅超声多普勒速度和脑血管病儿童的经颅超声多普勒速度,而无需输血支持:EXTEND 试验。
Br J Haematol. 2021 Nov;195(4):612-620. doi: 10.1111/bjh.17698. Epub 2021 Jul 22.
4
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).儿童期镰状细胞贫血羟脲治疗的多中心随机对照试验(BABY HUG)。
Lancet. 2011 May 14;377(9778):1663-72. doi: 10.1016/S0140-6736(11)60355-3.
5
Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial.羟基脲加量用于坦桑尼亚镰状细胞贫血儿童一级卒中预防(SPHERE):一项开放标签、2 期试验。
Lancet Haematol. 2023 Apr;10(4):e261-e271. doi: 10.1016/S2352-3026(22)00405-7. Epub 2023 Mar 1.
6
Hydroxyurea therapy in children severely affected with sickle cell disease.羟基脲疗法用于重症镰状细胞病患儿。
J Pediatr. 1996 Jun;128(6):820-8. doi: 10.1016/s0022-3476(96)70335-9.
7
Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study.贫血严重程度对镰状细胞贫血婴儿临床特征的影响:来自 BABY HUG 研究的分析。
Pediatr Blood Cancer. 2012 Oct;59(4):675-8. doi: 10.1002/pbc.24037. Epub 2011 Dec 20.
8
Hydroxyurea treatment and neurocognitive functioning in sickle cell disease from school age to young adulthood.羟基脲治疗对学龄期至青年期镰状细胞病患者神经认知功能的影响。
Br J Haematol. 2021 Oct;195(2):256-266. doi: 10.1111/bjh.17687. Epub 2021 Jul 16.
9
Interventions for preventing silent cerebral infarcts in people with sickle cell disease.镰状细胞病患者无症状性脑梗死的预防干预措施。
Cochrane Database Syst Rev. 2020 Apr 6;4(4):CD012389. doi: 10.1002/14651858.CD012389.pub3.
10
Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.输血预防镰状细胞病患者的原发性和继发性中风。
Cochrane Database Syst Rev. 2020 Jul 27;7(7):CD003146. doi: 10.1002/14651858.CD003146.pub4.

引用本文的文献

1
Neurocognitive Profile and Associated Factors Among Children Affected by Sickle Cell Disease in Kinshasa, Democratic Republic of Congo: A Cross-Sectional Study.刚果民主共和国金沙萨受镰状细胞病影响儿童的神经认知特征及相关因素:一项横断面研究
Children (Basel). 2024 Dec 14;11(12):1521. doi: 10.3390/children11121521.
2
Quantifying dilated perivascular spaces in children with sickle cell disease.定量评估镰状细胞病患儿的血管周围间隙扩张。
Pediatr Blood Cancer. 2024 Sep;71(9):e31150. doi: 10.1002/pbc.31150. Epub 2024 Jul 2.
3
Awareness, access, and communication: provider perspectives on early intervention services for children with sickle cell disease.认知、可及性与沟通:医疗服务提供者对镰状细胞病患儿早期干预服务的看法
Front Pediatr. 2024 Mar 25;12:1366522. doi: 10.3389/fped.2024.1366522. eCollection 2024.
4
Molecular and environmental contributors to neurological complications in sickle cell disease.镰状细胞病神经并发症的分子和环境因素。
Exp Biol Med (Maywood). 2023 Aug;248(15):1319-1332. doi: 10.1177/15353702231187646. Epub 2023 Sep 9.
5
Examining the influence of pain and fatigue on neurocognitive functioning in adolescents and young adults with sickle cell disease.探讨疼痛和疲劳对镰状细胞病青少年和年轻成人神经认知功能的影响。
Pediatr Blood Cancer. 2023 Nov;70(11):e30621. doi: 10.1002/pbc.30621. Epub 2023 Aug 10.
6
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2023 Aug 4;8(8):CD012380. doi: 10.1002/14651858.CD012380.pub3.
7
The Development of Neuroimaging Biomarkers for Cognitive Decline in Sickle Cell Disease.用于镰状细胞病认知衰退的神经影像学生物标志物的发展。
Hematol Oncol Clin North Am. 2022 Dec;36(6):1167-1186. doi: 10.1016/j.hoc.2022.07.011.
8
Hydroxyurea (hydroxycarbamide) for sickle cell disease.羟基脲(羟脲)治疗镰状细胞病。
Cochrane Database Syst Rev. 2022 Sep 1;9(9):CD002202. doi: 10.1002/14651858.CD002202.pub3.
9
Adaptive Functioning in Children and Adolescents With Sickle Cell Disease.镰状细胞病患儿和青少年的适应功能。
J Pediatr Psychol. 2022 Aug 12;47(8):939-951. doi: 10.1093/jpepsy/jsac024.
10
Neurocognitive functioning in preschool children with sickle cell disease.镰状细胞病学龄前儿童的神经认知功能。
Pediatr Blood Cancer. 2022 Mar;69(3):e29531. doi: 10.1002/pbc.29531. Epub 2021 Dec 31.

本文引用的文献

1
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).儿童期镰状细胞贫血羟脲治疗的多中心随机对照试验(BABY HUG)。
Lancet. 2011 May 14;377(9778):1663-72. doi: 10.1016/S0140-6736(11)60355-3.
2
Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia.神经认知功能障碍和神经影像学异常在神经完整的镰状细胞贫血成人中。
JAMA. 2010 May 12;303(18):1823-31. doi: 10.1001/jama.2010.562.
3
Design of the silent cerebral infarct transfusion (SIT) trial.无症状脑梗死输血(SIT)试验的设计。
Pediatr Hematol Oncol. 2010 Mar;27(2):69-89. doi: 10.3109/08880010903360367.
4
Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: baseline data from the BABY HUG trial.经颅多普勒超声(TCD)在镰状细胞贫血婴儿中的应用:BABY HUG 试验的基线数据。
Pediatr Blood Cancer. 2010 Feb;54(2):256-9. doi: 10.1002/pbc.22282.
5
The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design.儿科羟脲 III 期临床试验(BABY HUG):研究设计的挑战。
Pediatr Blood Cancer. 2010 Feb;54(2):250-5. doi: 10.1002/pbc.22269.
6
Silent infarcts in young children with sickle cell disease.镰状细胞病幼儿中的无症状性梗死
Br J Haematol. 2009 Aug;146(3):300-5. doi: 10.1111/j.1365-2141.2009.07753.x. Epub 2009 Jun 4.
7
Detection and assessment of stroke in patients with sickle cell disease: neuropsychological functioning and magnetic resonance imaging.镰状细胞病患者中风的检测与评估:神经心理功能与磁共振成像
Pediatr Hematol Oncol. 2008 Jun;25(5):409-21. doi: 10.1080/08880010802107497.
8
MRI abnormalities of the brain in one-year-old children with sickle cell anemia.镰状细胞贫血一岁儿童的脑部磁共振成像异常
Pediatr Blood Cancer. 2008 Nov;51(5):643-6. doi: 10.1002/pbc.21612.
9
Role of the red blood cell in nitric oxide homeostasis and hypoxic vasodilation.红细胞在一氧化氮稳态和缺氧性血管舒张中的作用。
Adv Exp Med Biol. 2006;588:189-205. doi: 10.1007/978-0-387-34817-9_17.
10
Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.解析镰状细胞病:重新评估溶血在临床亚表型发展中的作用。
Blood Rev. 2007 Jan;21(1):37-47. doi: 10.1016/j.blre.2006.07.001. Epub 2006 Nov 7.